Article Text

Download PDFPDF
Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
  1. D S Gombos1,2,5,
  2. P A Cauchi1,
  3. J L Hungerford1,2,
  4. P Addison1,
  5. P G Coen4,
  6. J E Kingston1,3
  1. 1Ocular Oncology Service, Bart’s and The London NHS Trust, London, UK
  2. 2Ocular Oncology Service, Moorfields Eye Hospital, London, UK
  3. 3Paediatric Oncology Service, Bart’s and The London NHS Trust, London, UK
  4. 4Academic Department of Child Health, Queen Mary, University of London, UK
  5. 5Section of Ophthalmology, Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA
  1. Correspondence to: MrJohn L Hungerford FRCS, Department of Ophthalmology, Ocular Oncology Service, St Bartholomew’s Hospital, West Smithfield, London EC1A 7BE, UK; paulcauchi{at}doctors.org.uk

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.